News - TopAbstracts in Pancreatic Cancer 10/21/2009

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Pancreatic Cancer

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Pancreatic Cancer

	TopAbstracts in Pancreatic Cancer 12/16/2009 - (DGNews)
	Low-Molecular-Weight Heparin Reduces Risk of Venous Clots in Patients With Pancreatic Cancer: Presented at ASH - (DGDispatch)
	Mesothelin a Marker for Pancreatic Tumours and Potential Target for Immunotherapy - (DGNews)
	Identification of a novel antibody associated with autoimmune pancreatitis - (N Engl J Med)
	Endoscopic Ultrasound-Fine Needle Aspiration Predicts 5-year Survival in Pancreatic Endocrine Tumours - (DGNews)

News archive

Recent webcasts/CME

Webcasts/CME archive

Recent cases - Pancreatic Cancer

	Acute Cholangitis Due To Pancreatic Metastasis From Squamous Cell Lung Carcinoma: A Case Report And Review Of Literature
	Small Invasive Ductal Carcinoma Of The Pancreas Distinct From Branch Duct Intraductal Papillary Mucinous Neoplasm
	Xanthogranulomatous Inflammation of the Peripancreatic Region Mimicking Pancreatic Cystic Neoplasm
	Pancreatic Ampullary Carcinoma with Neck Metastases: A Case Report
	Small Pancreatic Cancer with Pancreas Divisum Preoperatively Diagnosed by Pancreatic Juice Cytology

Cases archive

my personal edition > pancreatic cancer > news

E-Mail this item to a colleague

TopAbstracts in Pancreatic Cancer 10/21/2009

10/21/2009

TopAbstracts™ in Pancreatic Cancer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide™ newsletter or visited a website Powered by Doctor's Guide™ in the past 28 days. Over 2000 peer-reviewed journals are covered by TopAbstracts.

TopAbstracts - Past 28 days

Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie' - (Anti-Cancer Drugs)
Gemcitabine plus irinotecan as first-line weekly therapy in locally advanced and/or metastatic pancreatic cancer - (Oncol Res)
Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer - (Anti-Cancer Drugs)
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer - (Br J Cancer)
Novel agents for the treatment of adenocarcinoma of the pancreas - (Expert Rev Anticancer Ther)

TopAbstracts - Past 3 months

Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411 - (J Clin Oncol)
A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer - (Br J Cancer)
Second-line therapy for advanced pancreatic cancer: A review of the literature and future directions - (Cancer Treat Rev)
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone - (Br J Cancer)
Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia - (Eur J Gastroenterol Hepatol)

E-Mail this item to a colleague

To print, use this version